CCL2 and neoplasm: CCR2 and its cognate ligand, CCL2, are implicated in the infiltration of immunosuppressive cells into tumors, notably M2-like tumor-associated macrophages (TAMs; Schmall et al., 2015) and myeloid-derived suppressor cells (MDSCs; Hartwig et al., 2017).